INTERNATIONAL PATENT: MITSUBISHI TANABE PHARMA CORPORATION, 田辺三菱製薬株式会社 FILES APPLICATION FOR "COMPOUND AND PHARMACEUTICAL COMPOSITION FOR REGULATING MYOREGULIN EXPRESSION"

GENEVA, Oct. 5 -- MITSUBISHI TANABE PHARMA CORPORATION (3-2-10, Dosho-machi, Chuo-ku, Osaka-shi, Osaka5418505), 田辺三菱製薬株式会社 (大阪府大阪市中央区道修町三丁目２番１０号) filed a patent application (PCT/JP2025/012308) for "COMPOUND AND PHARMACEUTICAL COMPOSITION FOR REGULATING MYOREGULIN EXPRESSION" on Mar 27, 2025. With publication no. WO/2025/206092, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the Wo...